Atlas Trials

The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers

Clinical trial NCT03211572 · UNKNOWN

Trial details

NCT number
NCT03211572
Sponsor
Ottawa Hospital Research Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-08-01
Primary completion
2018-08-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.